Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.

[1]  S. Sarin,et al.  World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2014, Journal of clinical gastroenterology.

[2]  A. Alisi,et al.  Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[3]  R. Shamir,et al.  Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. , 2013, World journal of gastroenterology.

[4]  R. Betensky,et al.  Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome. , 2013, Gastroenterology.

[5]  D. Tiniakos,et al.  The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease , 2013, Journal of clinical gastroenterology.

[6]  A. Lorenzo,et al.  A pathogenetic link between non-alcoholic fatty liver disease and celiac disease , 2013, Endocrine.

[7]  A. Kahraman,et al.  Non-Alcoholic Steatohepatitis Occurs in Celiac Disease and is Associated with Cellular Stress , 2013, Zeitschrift für Gastroenterologie.

[8]  G. Choudhuri,et al.  Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. , 2012, World journal of hepatology.

[9]  F. Rasmussen,et al.  Socioeconomic position and education in patients with coeliac disease. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[10]  S. Bischoff,et al.  Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) , 2012, Digestive Diseases and Sciences.

[11]  J. Abed,et al.  Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis , 2011, Gut.

[12]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[13]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[14]  G. Bhagat,et al.  Celiac Disease in Normal-weight and Overweight Children: Clinical Features and Growth Outcomes Following a Gluten-free Diet , 2011, Journal of pediatric gastroenterology and nutrition.

[15]  H. Ghofrani,et al.  The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. , 2011, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[16]  D. Sanders,et al.  Risk of tuberculosis in a large sample of patients with coeliac disease – a nationwide cohort study , 2011, Alimentary pharmacology & therapeutics.

[17]  J. Murray,et al.  Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. , 2010, Gastroenterology.

[18]  A. Alisi,et al.  Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children , 2010, Journal of pediatric gastroenterology and nutrition.

[19]  P. Rosenthal,et al.  Association Between Metabolic Syndrome and Liver Histology Among Children With Nonalcoholic Fatty Liver Disease , 2010, The American Journal of Gastroenterology.

[20]  P. Green,et al.  Body Mass Index in Celiac Disease: Beneficial Effect of a Gluten-free Diet , 2010, Journal of clinical gastroenterology.

[21]  E. Jackvony,et al.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.

[22]  M. V. van Oijen,et al.  Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis , 2009, BMC gastroenterology.

[23]  M. Mino‐Kenudson,et al.  Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. , 2009, Archives of pathology & laboratory medicine.

[24]  F. Granath,et al.  Small-intestinal histopathology and mortality risk in celiac disease. , 2009, JAMA.

[25]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[26]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[27]  F. Granath,et al.  Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers , 2009, BMC gastroenterology.

[28]  J. Rosenblatt,et al.  Prevalence of Small Intestine Bacterial Overgrowth Diagnosed by Quantitative Culture of Intestinal Aspirate in Celiac Disease , 2009, Journal of clinical gastroenterology.

[29]  J. Ludvigsson,et al.  Coeliac disease and body mass index: A study of two Swedish general population-based registers , 2009, Scandinavian journal of gastroenterology.

[30]  C. Sirlin,et al.  Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.

[31]  D. Sanders,et al.  Coeliac disease and risk of tuberculosis: a population-based cohort study , 2006, Thorax.

[32]  L. N. Valenti,et al.  Searching for coeliac disease in patients with non-alcoholic fatty liver disease. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[33]  S. Caldwell,et al.  The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. , 2004, Journal of hepatology.

[34]  G. Maggiore,et al.  The liver in celiac disease. , 2003, Journal of pediatric gastroenterology and nutrition.

[35]  U. Peters,et al.  Causes of death in patients with celiac disease in a population-based Swedish cohort. , 2003, Archives of internal medicine.

[36]  I. Roberts-Thomson,et al.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis , 2001, Gut.

[37]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[38]  D. H. Thomas,et al.  Luminal bacteria and small-intestinal permeability. , 1997, Scandinavian journal of gastroenterology.

[39]  M. Gerhart,et al.  Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing , 1994, Nature.

[40]  C. Mulder,et al.  Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. , 1993, Gut.

[41]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[42]  K. Kawagoe,et al.  Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. , 1987, The American journal of gastroenterology.

[43]  Union Européenne.  Health at a Glance: Europe 2010 , 2010 .

[44]  J. Ludvigsson,et al.  Celiac disease and risk of liver disease: a general population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[45]  B. Smedby,et al.  Evaluation of the data quality in the Swedish national hospital discharage register , 1998 .